Alan Walts

Dr. Alan Walts joined the Board on April 1, 2021, and previously served as Executive Chairman of Zikani since May 2020. Dr. Walts is a U.S.-based Venture Partner with Advent Life Sciences, a position he has held since January 2014. Dr. Walts has served as Executive Chairman and Director of PIC Therapeutics since 2016 and Artax Biopharma since 2017. Dr. Walts is also a founder, director and treasurer of The Termeer Foundation, a public 501(c)(3) organization founded in 2019. He serves as an independent Director of Neuroelectrics Corp, and a business advisor and board observer of several private companies including Amylyx Pharmaceuticals, Arrakis Therapeutics, Alpha Anomeric and Amphista Therapeutics. Dr. Walts’ previous board experience includes X4 Pharmaceuticals, Aura Biosciences, and Arrakis Therapeutics. Dr. Walts has over 25 years of industry experience at Genzyme in business development, business strategy, research and development, general management, and venture capital. Prior to leaving Genzyme in 2013, Dr. Walts most recently managed Genzyme’s corporate venture fund, Genzyme Ventures (now Sanofi Ventures). Dr. Walts received a Ph.D. in chemistry from MIT in 1985, carried out post-doctoral research in biochemistry at MIT with Professor Christopher Walsh, and completed the executive Program for Management Development at Harvard Business School.